DMD and Duchenne muscular dystrophy: Our results in β-spectrin quantification suggest that this sarcolemma protein is not suitable for normalizing dystrophin intensity levels and, consequently, it might be pertinent to identify a different membrane protein whose expression is not affected in patients with DMD and BMD.